Financhill
Back

Cassava Sciences Quote, Financials, Valuation and Earnings

Cassava Sciences Price Quote

$3.49
-0.35 (-9.11%)
(Updated: December 2, 2024 at 12:25 PM ET)

Cassava Sciences Key Stats

Sell
20
Cassava Sciences (SAVA) is a Sell

Day range:
$3.77 - $4.00
52-week range:
$3.65 - $42.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.21
P/B ratio:
1.11%

Volume:
15.8M
Avg. volume:
7M
1-year change:
-81.3%
Market cap:
$184.7M
Revenue:
$0
EPS:
$-1.38

How Much Does Cassava Sciences Make?

Data Unavailable

Is Cassava Sciences Growing As A Company?

Data Unavailable

Cassava Sciences Stock Price Performance

  • Did Cassava Sciences Stock Go Up Last Month?
    Cassava Sciences share price went down by -85.52% last month
  • Did SAVA's Share Price Rise Over The Last Year?
    SAVA share price fell by -81.3% over the past 1 year

What Is Cassava Sciences 52-Week High & Low?

Cassava Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cassava Sciences?

  • How Much Debt Does Cassava Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cassava Sciences Have?
    Cash and short term investments quarterly total is $149M
  • What Is Cassava Sciences’s Book Value Per Share?
    Book value per share is 3.47

Is Cassava Sciences Cash Flow Positive?

  • What Is SAVA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$78M
  • What Is Cassava Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $124.7M
  • What Is Cassava Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$87K

Cassava Sciences Return On Invested Capital

Data Unavailable

Cassava Sciences Earnings Date & Stock Price

Cassava Sciences Competitors

  • Who Are Cassava Sciences's Competitors?
    Below is a list of companies who compete with Cassava Sciences or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • BridgeBio Pharma Inc (BBIO)
    • Bristol-Myers Squibb Co (BMY)
    • EyePoint Pharmaceuticals Inc (EYPT)

Cassava Sciences Dividend Yield

Cassava Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 34.09%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 116.00
Upside from Last Price: 2920.83%

Major Shareholders

  • How many SAVA shares are owned by institutional investors?
    20.8M SAVA shares are owned by institutional investors
  • How many SAVA shares are owned by insiders?
    2M SAVA shares are owned by insiders